StonvexLoading…
StonvexStonvexStonvexCore line items from PBYI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $228.37M | $230.47M | $235.64M | $228.03M |
Operating Income | $37.30M | $30.97M | $32.64M | $23.72M |
Net Income | $31.11M | $30.28M | $21.59M | $2.00K |
EPS (Diluted) | $0.61 | $0.62 | $0.45 | $0.00 |
Total Assets | $216.30M | $213.33M | $230.53M | $222.06M |
Total Liabilities | $85.96M | $121.21M | $177.09M | $200.45M |
Cash & Equivalents | $29.64M | $69.22M | $84.58M | $76.20M |
Free Cash Flow OCF − CapEx | $41.73M | $38.86M | $26.87M | $-15.83M |
Shares Outstanding | 50.41M | 49.11M | 47.65M | 46.35M |